Literature DB >> 27154889

Liver Transplantation in 2016: An Update.

Carl L Berg1.   

Abstract

Liver transplantation is a lifesaving intervention for patients with decompensated cirrhosis, certain malignancies, and genetic disorders associated with disordered liver metabolism. This commentary will discuss the indications for liver transplantation, the evaluation of liver transplant candidates, prioritization of candidates on the waiting list, and post-transplant care. ©2016 by the North Carolina Institute of Medicine and The Duke Endowment. All rights reserved.

Entities:  

Mesh：

Year:  2016        PMID： 27154889     DOI： 10.18043/ncm.77.3.194

Source DB:  PubMed          Journal:  N C Med J        ISSN： 0029-2559


  3 in total

1.  Incidence of Recurrent NASH-Related Allograft Cirrhosis.

Authors:  Shelly Kakar; Mohannad Dugum; Ricardo Cabello; Abhinav Humar; Jawad Ahmad; Shahid M Malik
Journal:  Dig Dis Sci       Date:  2018-12-17       Impact factor: 3.199

2.  Sixteen-Year Cohort of Liver Transplantation in the National Health System in Brazil: Analysis of Immunosuppression Maintenance Therapies.

Authors:  Guilherme Fagundes Nascimento; Rosângela Maria Gomes; Juliana Alvares-Teodoro; Nélio Gomes Ribeiro; Mariângela Leal Cherchiglia; Charles Simão-Filho; Francisco Assis Acurcio; Tulio Tadeu Rocha Sarmento; Ludmila Peres Gargano; Augusto Afonso Guerra
Journal:  Front Pharmacol       Date:  2020-10-06       Impact factor: 5.810

3.  Rifaximin has the potential to prevent complications of cirrhosis.

Authors:  Steven L Flamm; Kevin D Mullen; Zeev Heimanson; Arun J Sanyal
Journal:  Therap Adv Gastroenterol       Date:  2018-09-28       Impact factor: 4.409
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.